Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CCKBR | P32239 | 14/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6177751 | 0.92 | CYP3A4 (0.46) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6176880 | 0.90 | CYP3A4 (0.47) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6179745 | 0.89 | CCKBR (0.51) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6180216 | 0.88 | CCKBR (0.50) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6179396 | 0.86 | CYP3A4 (0.43) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6175491 | 0.86 | CYP3A4 (0.46) | CYP3A4MAPTTSHRCCKBRRAB9A | |
| SCHEMBL6179079 | 0.86 | CCKBR (0.49) | CYP3A4MAPTTSHRCCKBRPOLB | |
| SCHEMBL6177008 | 0.86 | CYP3A4 (0.44) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6177761 | 0.85 | CYP3A4 (0.57) | CYP3A4MAPTTSHRCCKBR | |
| SCHEMBL6177850 | 0.84 | CCKBR (0.45) | CYP3A4MAPTTSHRCCKBRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |